• GSK, after pushing past midphase fail, ends development of otilimab in COVID-19

    1 month ago - By Fierce Biotech

    GSK, after pushing past midphase fail, ends development of otilimab in COVID-19 ntaylor
    Wed, 10/27/2021 - 08:58
    Read more ...